Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY

NCT00235222 is registered in ClinicalTrials.gov with Groupe Hospitalier Pitie-Salpetriere as lead sponsor.

NCT NCT00235222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00235222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY
Lead sponsor
Groupe Hospitalier Pitie-Salpetriere
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2004
Completion date
March 31, 2006
Enrollment
57
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv